ProfileGDS5678 / 1446850_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 49% 49% 62% 51% 51% 46% 46% 48% 50% 61% 48% 50% 47% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2151449
GSM967853U87-EV human glioblastoma xenograft - Control 23.1599349
GSM967854U87-EV human glioblastoma xenograft - Control 33.6994462
GSM967855U87-EV human glioblastoma xenograft - Control 43.1699151
GSM967856U87-EV human glioblastoma xenograft - Control 53.1881351
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1775846
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1490946
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1333548
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1761550
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.6379161
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1252948
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1556250
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1274647
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2438252